monoclonal antibodies
FDA Approves Fasenra for EGPA
The FDA approved Fasenra for adults with eosinophilic granulomatosis with polyangiitis.
SEPTEMBER 19, 2024
FDA Approves Veopoz for CHAPLE Disease
The FDA approved Veopoz as the first treatment for CD55-deficient protein-losing enteropathy, also known as CHAPLE ...
AUGUST 21, 2023
FDA Grants New Indication for Tezspire for Self-Administration
The monoclonal antibody Tezspire received a new indication to allow self-administration in a prefilled, single-use ...
FEBRUARY 3, 2023
Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus
Multiple sites of the Epstein-Barr virus appear to be vulnerable. A panel of investigational monoclonal antibodies ...
NOVEMBER 10, 2022
5 Skills for Navigating the Pandemic With EUA Therapies
Specialty and infusion pharmacies have been playing a critical role in making a frequently changing menu of infused ...
JULY 15, 2022
FDA Expands Authorization for Evusheld; Authorizes Bebtelovimab for COVID-19
The FDA revised the EUA for tixagevimab-cligavimab to allow a higher dose for PrEP and also granted a new EUA to ...
MARCH 1, 2022
Arsenal Against Omicron Weakening
At least two Mabs available under the FDA emergency use authorization are not as effective against omicron as ...
JANUARY 13, 2022
Pharmacists Authorized to Order and Administer COVID-19 Therapeutics Under PREP Act Declaration
An amendment to the PREP Act broadly addresses the pharmacist's role in providing COVID-19 therapeutics, including ...
SEPTEMBER 17, 2021
Safe at Home: mAb Infusions for COVID-19
Home infusion providers can successfully administer monoclonal antibody (mAb) therapy to COVID-19 patients in ...
MAY 27, 2021
FDA Revokes EUA for Bamlanivimab Monotherapy for COVID-19; Still Authorized in Combination
Although the FDA revoked its EUA for bamlanivimab monotherapy, the agency said it could still be given ...
APRIL 21, 2021
